全球HLA型檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

HLA型檢測市場預計將從 2025 年的 13.9 億美元成長到 2034 年的 25.7 億美元，2026 年至 2034 年的複合年成長率為 7.04%。

由於器官移植手術數量的增加以及人們對組織相容性檢測意識的提高，全球HLA型檢測市場正經歷顯著成長。人類白血球抗原（HLA）分型在骨髓和固態器官移植中發揮著至關重要的作用。慢性疾病導致的器官衰竭病例不斷增加，推動了全球對精準、先進的HLA檢測解決方案的需求。

關鍵成長要素包括分子診斷技術的進步，例如次世代定序(NGS) 和基於 PCR 的檢測。捐贈者登記系統的擴展和政府對移植項目的支持也促進了市場成長。免疫學和個人化醫療領域的研究進一步增強了臨床和研究環境中對精準HLA型檢測的需求。

預計未來成長將主要由技術創新、檢查室自動化以及全球器官移植數量的增加所驅動。新興市場對醫療基礎設施的投資正在不斷推進，從而創造了新的機會。此外，生物資訊工具的整合將提高數據分析的準確性，進而提升檢測的精確度和效率，從而支持市場的持續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球HLA型檢測市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 試劑和耗材
• 軟體和服務

第5章：全球HLA型檢測市場：依應用領域分類

• 市場分析、洞察與預測
• 診斷
• 研究

第6章：全球HLA型檢測市場：依方法論分類

• 市場分析、洞察與預測
• 分子檢測
• 基於序列的分子檢測
• 非分子檢測

第7章 全球HLA型檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 商業服務供應商
• 醫院及移植中心
• 研究機構和學術機構

第8章：全球HLA型檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • Qiagen NV
  • Omixon Inc
  • GenDx
  • Illumina Inc
  • TBG Diagnostics Limited
  • Dickinson And Company
  • Takara Bio Inc
  • F. Hoffman-La Roche Limited
  • Pacific Biosciences

The HLA Typing Market size is expected to reach USD 2.57 Billion in 2034 from USD 1.39 Billion (2025) growing at a CAGR of 7.04% during 2026-2034.

The Global HLA Typing Market is witnessing strong growth due to increasing organ transplantation procedures and rising awareness about tissue compatibility testing. Human Leukocyte Antigen (HLA) typing plays a critical role in bone marrow and solid organ transplants. Growing cases of chronic diseases leading to organ failure are boosting demand for accurate and advanced HLA testing solutions worldwide.

Key growth drivers include advancements in molecular diagnostic technologies such as next-generation sequencing (NGS) and PCR-based assays. Expanding donor registries and government support for transplant programs are also contributing to market growth. Research in immunology and personalized medicine further strengthens the demand for precise HLA typing in clinical and research settings.

Future growth is expected to be driven by technological innovations, automation in laboratories, and increasing global transplant volumes. Emerging markets are investing in healthcare infrastructure, which will create new opportunities. Additionally, the integration of bioinformatics tools for improved data analysis will enhance testing accuracy and efficiency, supporting sustained market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instruments
• Reagents & Consumables
• Software & Services

By Application

• Diagnosis
• Research

By Technique

• Molecular Assay
• Sequenced-based Molecular Assay
• Non-Molecular Assay

By End User

• Commercial Service Providers
• Hospitals and Transplant Centers
• Research Labs & Academic Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, BioRad Laboratories Inc, Qiagen NV, Omixon Inc, GenDx, Illumina Inc, TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc, F HoffmanLa Roche Limited, Pacific Biosciences
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HLA TYPING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HLA TYPING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HLA TYPING MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technique
• 6.2. Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequenced-based Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Non-Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HLA TYPING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Commercial Service Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals and Transplant Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Labs & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HLA TYPING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Technique
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Technique
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Technique
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Technique
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Technique
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HLA TYPING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Bio-Rad Laboratories Inc
  • 10.2.3 Qiagen N.V
  • 10.2.4 Omixon Inc
  • 10.2.5 GenDx
  • 10.2.6 Illumina Inc
  • 10.2.7 TBG Diagnostics Limited
  • 10.2.8 Dickinson And Company
  • 10.2.9 Takara Bio Inc
  • 10.2.10 F. Hoffman-La Roche Limited
  • 10.2.11 Pacific Biosciences